# AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy

> **NCT07049627** · — · COMPLETED · sponsor: **Ankara Etlik City Hospital** · enrollment: 93 (actual)

## Conditions studied

- Locally Advanced Rectal Cancer (LARC)

## Interventions

- **OTHER:** Total Neoadjuvant Therapy (TNT)

## Key facts

- **NCT ID:** NCT07049627
- **Lead sponsor:** Ankara Etlik City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-05
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07049627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07049627, "AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07049627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*